目的 对比研究2种不同苦参碱自纳米乳化制剂肠淋巴转运差异。方法 采用大鼠三重在体单向肠灌流(T-SPIP)实验, 以苦参碱原药为参比, 利用乳糜流动阻断剂(秋水仙碱), 对比研究2种不同苦参碱自纳米乳化制剂在大鼠不同肠段淋巴吸收特性的差异。结果 自乳化制剂粒径小且分布均匀, 在大鼠的不同肠段均有较高吸收, 苦参碱磷脂复合物自纳米乳化制剂(MPC-SN)在回肠段渗透系数最高, 且受乳糜流动阻断剂的影响最大。结论 自乳化制剂可通过肠淋巴通道增加药物吸收。脂溶性高且粒径较小的苦参碱-磷酸复合物自乳化纳米粒(MPC-SN)更易经肠淋巴系统转运。
Abstract
OBJECTIVE To investigate the differences of two matrine (MA) self-nanoemulsifying drug delivery systems (SNEDDS) in intestinal lymphatic transport.METHODS Triple single pass intestinal perfusion model (T-SPIP) was established to study the intestinal absorption kinetics of MA in different absorption segments of rats with chylomicron flow blocking approach using colchicine as the blocker. The concentration of MA in the perfustae was measured by HPLC. RESULTS The two SNEDDSs had regular spherical surface and narrow particle size distribution. MA showed high Peff. The phospholipid complex formulation (MPC-SN) exhibited higher intestinal lymphatic transport especially in distal ileum, and it was influenced more significantly by the chylomicron flow blocker in distal ileum compared to in proximal jejunum and mid-small intestine. CONCLUSION SNEDDS can improve the absorption of MA by intestinal lymphatic transport. MPC-SN might be easier to be absorbed via lymphatic transport because of its high lipophilicity and small particle size.
关键词
苦参碱 /
自纳米乳化制剂 /
三重在体单向肠灌流 /
乳糜流动阻断剂
{{custom_keyword}} /
Key words
matrine /
self-nanoemulsifying drug delivery systems (SNEDDS) /
T-SPIP /
chylomicron flow blocker
{{custom_keyword}} /
中图分类号:
R286
R965
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
LIU M, LIU X Y, CHENG J F. Advance in the pharmacological research on matrine . China J Chin Mate Med(中国中药杂志), 2003, 28(9):801-804. YANG Z, GAO S, YIN T J, et al.Biopharmaceutical and pharmacokinetic characterization of matrine as determined by a sensitive and robust UPLC-MS/MS method . J Pharm Bio Anal, 2010, 51(5): 1120-1127. RUAN J H, LIU J, ZHU D, et al. Preparation and evaluation of self-nanoemulsified drug delivery systems (SNEDDSs) of matrine based on drug-phospholipid complex technique. Int J Pharm, 2010, 386(1-2): 282-290. LIU W Y, LIU H Q. Preparation of matrine liposome by active loading method. Lishizhen Med Mater Med Res(时珍国医国药), 2007, 18(4): 908-909. LIU D Y, MA J X, CAO D Y, et al. Sustained release ability and safety of matrine polyactic acid microsphere intravitreal injection. Chin Ophthal Res (眼科研究), 2010, 28(1): 34-38. NAZZAL S, SMALYUKH I I, LAVRENTOVICH O D, et al. Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: Mechanism and progress of emulsion formation . Int J Pharm, 2002, 235(1-2): 247-265. SHAH R B, ZIDAN A S, FUNCK T, et al. Quality by design: Characterization of self-nano-emulsified drug delivery systems (SNEDDs) using ultrasonic resonator technology . Int J Pharm, 2007, 341(1-2): 189-194. YNEZ J A, WANG S W J, KNEMEYER I W. Intestinal lymphatic transport for drug delivery . Adv Drug Deliv Rev, 2011, 63(10-11): 923-942. TEUTONICO D, MONTANARI S, PONCHEL G. Concentration and surface of absorption: Concepts and applications to gastrointestinal patches delivery . Int J Pharm, 2011, 413(1-2):87- 92. DAHAN A, HOFFMAN A. Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs. Eur J Pharm Sci, 2005, 24(4): 381-388. SUN M H, ZHAI X Z, XUE K W, et al. Intestinal absorption and intestinal lymphatic transport of sirolimus from self-microemulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: Linear correlation with oral bioavailabilities in rats. Eur J Pharm Sci, 2011, 43(3): 132-140. DAHAN A, WEST B T, AMIDON G L. Segmental-dependent membrane permeability along the intestine following oral drug administration: Evaluation of a triple single-pass intestinal perfusion (TSPIP) approach in the rat. Eur J Pharm Sci, 2009, 36(2-3):320-329. STUDANTE M, MORAIS J G, SOVERAL G, et al. Intestinal drug transporters: An overview. Adv Drug Deliv Rev, 2013, 65(10):1340-1356. PORTER C J H, TREVASKIS N L, CHARMAN W N. Lipids and lipid-based formulations: Optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov, 2007, 6(3): 231-248. MURANISHI S, FUJITA T, MURAKAMI M, et al. Potential for lymphatic targeting of peptides . J Controlled Release, 1997, 46(1-2): 157-164. LIND M L, JACOBSEN J, HOLM R, et al. Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: The influence of polysorbate 60 and 80. Eur J Pharm Sci, 2008, 35(3):211-218.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
贵州省优秀科技教育人才省长专项基金(2011-13);贵州省中药现代化专项(黔科合中药字5039)
{{custom_fund}}